AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2012
Aug 30, 2012
34117_dirs_2012-08-30_768b0e6d-2caa-4248-8cf2-4312c06f91d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2012-08-21
Reporting Person: Williams Kent B. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| CopyTele, Inc. common stock | 111210 | Direct |
| CopyTele, Inc. common stock | 99540 | Indirect |
| CopyTele, Inc. common stock | 215460 | Indirect |
| CopyTele, Inc. common stock | 47700 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy) | $0.1105 | 2017-08-26 | Common Stock (60000) | Direct |
Footnotes
F1: Consists of shares owned through the Vista Asset Management 401(k) plan. The reporting person and his wife are the trustees of this plan.
F2: Consists of shares owned by the reporting person's wife through the Vista Asset Management 401(k) plan. The reporting person disclaims beneficial ownership of the shares.
F3: Consists of shares owned by the reporting person's wife. The reporting person disclaims beneficial ownership of the shares.
F4: Pursuant to CopyTele, Inc. 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6